"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 4 | 6 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 4 | 3 | 7 |
| 2013 | 1 | 2 | 3 |
| 2014 | 4 | 2 | 6 |
| 2015 | 1 | 2 | 3 |
| 2016 | 3 | 5 | 8 |
| 2017 | 75 | 69 | 144 |
| 2018 | 71 | 66 | 137 |
| 2019 | 23 | 31 | 54 |
| 2020 | 2 | 3 | 5 |
| 2021 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic. Am J Clin Nutr. 2021 11 08; 114(5):1655-1665.
-
Diabetes and susceptibility to infections: Implication for COVID-19. Immunology. 2021 11; 164(3):467-475.
-
Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports. BMC Pregnancy Childbirth. 2021 Jun 16; 21(1):427.
-
Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance. Immunopharmacol Immunotoxicol. 2021 Jun; 43(3):265-270.
-
Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance. Mol Metab. 2021 11; 53:101262.
-
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021 06; 3(6):774-785.
-
Not so sweet and simple: impacts of SARS-CoV-2 on the ß cell. Islets. 2021 07 04; 13(3-4):66-79.
-
COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study. Endocr Pract. 2021 Aug; 27(8):834-841.
-
Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells. 2021 04 17; 10(4).
-
Insulin resistance in COVID-19 and diabetes. Prim Care Diabetes. 2021 08; 15(4):629-634.